lobbying_activities: 1615911

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1615911	b9060d1e-336f-46e3-bec2-9051451ef90c	4T	SLC HEALTH STRATEGIES, LLC	401018877	CUBIST PHARMACEUTICALS, INC.	2014	fourth_quarter	PHA	Implementation of the "GAIN" provisions/Title VIII of the Food and Drug Administration Safety and Innovation Act (FDASIA) - PL 112-144; antibiotic product development incentive, limited population antibiotic product (LPAD) and breakpoint legislation HR 3742 -- the Antibiotic Development to Advance Patient Treatment Act of 2013 H.R.4187 -- Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2014 antibiotic product incentives for possible inclusion in the House "21st Century Cures" effort	HOUSE OF REPRESENTATIVES,SENATE	60000		0	1	2014-12-29T13:05:39.897000-05:00